Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus

S.R. McPhee, K.L. Butler, John Kovaliski, Greg Mutze, Lorenzo Capucci, Brian Cooke

    Research output: Contribution to journalArticle

    21 Citations (Scopus)

    Abstract

    In Australia, the epidemiology of rabbit haemorrhagic disease virus (RHDV) is complicated by non-pathogenic forms of calicivirus (bCV) co-circulating with RHDV and providing variable protection from RHDV. Currently no bCV virus-specific antibody tests exist; however, a series of four ELISAs used to detect antibodies to RHDV provided an indirect means to detect antibodies to bCV, enabling antibody categories of seronegative, maternal RHDV, RHDV or bCV to be determined. Rabbits (188) from four locations were challenged with RHDV and logistic regression models determined that, for rabbits 15 months old, survival was dependent on antibody titres alone and the relationship did not vary with age, capture site, gender, liveweight or reproductive status. All rabbits survived challenge after reaching 15 months of age, irrespective of their antibody titres. Where bCV antibodies were prevalent in young rabbits, the bCV category did not adequately summarise all information about rabbit survival that can be obtained from antibody titres. Within antibody categories, 95% of rabbits with RHDV, 33% with bCV, 40% with maternal RHDV and 22% with seronegative antibodies survived. The high survival rate of adults implies that natural outbreaks or controlled releases of RHDV will have little impact on adult breeding rabbits. Therefore, where RHDV and bCV are endemic, conventional rabbit-control programs targeting the immune breeding populations should provide the most predictable outcome for long-term maintenance of low rabbit populations.
    Original languageEnglish
    Pages (from-to)447-456
    Number of pages10
    JournalWildlife Research
    Volume36
    Issue number5
    DOIs
    Publication statusPublished - 2009

    Fingerprint

    Rabbit hemorrhagic disease virus
    antibody
    virus
    rabbits
    antibodies
    Vesivirus
    reproductive status
    breeding
    breeding population
    epidemiology
    targeting

    Cite this

    McPhee, S. R., Butler, K. L., Kovaliski, J., Mutze, G., Capucci, L., & Cooke, B. (2009). Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus. Wildlife Research, 36(5), 447-456. https://doi.org/10.1071/WR08137
    McPhee, S.R. ; Butler, K.L. ; Kovaliski, John ; Mutze, Greg ; Capucci, Lorenzo ; Cooke, Brian. / Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus. In: Wildlife Research. 2009 ; Vol. 36, No. 5. pp. 447-456.
    @article{5fea226841634c6da0a149f005015a3a,
    title = "Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus",
    abstract = "In Australia, the epidemiology of rabbit haemorrhagic disease virus (RHDV) is complicated by non-pathogenic forms of calicivirus (bCV) co-circulating with RHDV and providing variable protection from RHDV. Currently no bCV virus-specific antibody tests exist; however, a series of four ELISAs used to detect antibodies to RHDV provided an indirect means to detect antibodies to bCV, enabling antibody categories of seronegative, maternal RHDV, RHDV or bCV to be determined. Rabbits (188) from four locations were challenged with RHDV and logistic regression models determined that, for rabbits 15 months old, survival was dependent on antibody titres alone and the relationship did not vary with age, capture site, gender, liveweight or reproductive status. All rabbits survived challenge after reaching 15 months of age, irrespective of their antibody titres. Where bCV antibodies were prevalent in young rabbits, the bCV category did not adequately summarise all information about rabbit survival that can be obtained from antibody titres. Within antibody categories, 95{\%} of rabbits with RHDV, 33{\%} with bCV, 40{\%} with maternal RHDV and 22{\%} with seronegative antibodies survived. The high survival rate of adults implies that natural outbreaks or controlled releases of RHDV will have little impact on adult breeding rabbits. Therefore, where RHDV and bCV are endemic, conventional rabbit-control programs targeting the immune breeding populations should provide the most predictable outcome for long-term maintenance of low rabbit populations.",
    author = "S.R. McPhee and K.L. Butler and John Kovaliski and Greg Mutze and Lorenzo Capucci and Brian Cooke",
    year = "2009",
    doi = "10.1071/WR08137",
    language = "English",
    volume = "36",
    pages = "447--456",
    journal = "Australian Wildlife Research",
    issn = "1035-3712",
    publisher = "CSIRO",
    number = "5",

    }

    McPhee, SR, Butler, KL, Kovaliski, J, Mutze, G, Capucci, L & Cooke, B 2009, 'Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus', Wildlife Research, vol. 36, no. 5, pp. 447-456. https://doi.org/10.1071/WR08137

    Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus. / McPhee, S.R.; Butler, K.L.; Kovaliski, John; Mutze, Greg; Capucci, Lorenzo; Cooke, Brian.

    In: Wildlife Research, Vol. 36, No. 5, 2009, p. 447-456.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Antibody status and survival of Australian wild rabbits challenged with rabbit haemorrhagic disease virus

    AU - McPhee, S.R.

    AU - Butler, K.L.

    AU - Kovaliski, John

    AU - Mutze, Greg

    AU - Capucci, Lorenzo

    AU - Cooke, Brian

    PY - 2009

    Y1 - 2009

    N2 - In Australia, the epidemiology of rabbit haemorrhagic disease virus (RHDV) is complicated by non-pathogenic forms of calicivirus (bCV) co-circulating with RHDV and providing variable protection from RHDV. Currently no bCV virus-specific antibody tests exist; however, a series of four ELISAs used to detect antibodies to RHDV provided an indirect means to detect antibodies to bCV, enabling antibody categories of seronegative, maternal RHDV, RHDV or bCV to be determined. Rabbits (188) from four locations were challenged with RHDV and logistic regression models determined that, for rabbits 15 months old, survival was dependent on antibody titres alone and the relationship did not vary with age, capture site, gender, liveweight or reproductive status. All rabbits survived challenge after reaching 15 months of age, irrespective of their antibody titres. Where bCV antibodies were prevalent in young rabbits, the bCV category did not adequately summarise all information about rabbit survival that can be obtained from antibody titres. Within antibody categories, 95% of rabbits with RHDV, 33% with bCV, 40% with maternal RHDV and 22% with seronegative antibodies survived. The high survival rate of adults implies that natural outbreaks or controlled releases of RHDV will have little impact on adult breeding rabbits. Therefore, where RHDV and bCV are endemic, conventional rabbit-control programs targeting the immune breeding populations should provide the most predictable outcome for long-term maintenance of low rabbit populations.

    AB - In Australia, the epidemiology of rabbit haemorrhagic disease virus (RHDV) is complicated by non-pathogenic forms of calicivirus (bCV) co-circulating with RHDV and providing variable protection from RHDV. Currently no bCV virus-specific antibody tests exist; however, a series of four ELISAs used to detect antibodies to RHDV provided an indirect means to detect antibodies to bCV, enabling antibody categories of seronegative, maternal RHDV, RHDV or bCV to be determined. Rabbits (188) from four locations were challenged with RHDV and logistic regression models determined that, for rabbits 15 months old, survival was dependent on antibody titres alone and the relationship did not vary with age, capture site, gender, liveweight or reproductive status. All rabbits survived challenge after reaching 15 months of age, irrespective of their antibody titres. Where bCV antibodies were prevalent in young rabbits, the bCV category did not adequately summarise all information about rabbit survival that can be obtained from antibody titres. Within antibody categories, 95% of rabbits with RHDV, 33% with bCV, 40% with maternal RHDV and 22% with seronegative antibodies survived. The high survival rate of adults implies that natural outbreaks or controlled releases of RHDV will have little impact on adult breeding rabbits. Therefore, where RHDV and bCV are endemic, conventional rabbit-control programs targeting the immune breeding populations should provide the most predictable outcome for long-term maintenance of low rabbit populations.

    U2 - 10.1071/WR08137

    DO - 10.1071/WR08137

    M3 - Article

    VL - 36

    SP - 447

    EP - 456

    JO - Australian Wildlife Research

    JF - Australian Wildlife Research

    SN - 1035-3712

    IS - 5

    ER -